Skip to search formSkip to main contentSkip to account menu

ajulemic acid

National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Tetrahydrocannabinol
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2014
Review
2014
The cannabinoid acids, analogs and endogenous counterparts.
2014
2014
Inhibition of Voltage-Gated Na+ Channels by the Synthetic Cannabinoid Ajulemic Acid
BACKGROUND:The synthetic cannabinoid ajulemic acid has been demonstrated to alleviate pain in patients suffering from chronic… 
2013
2013
In vitro metabolism and metabolic effects of ajulemic acid, a synthetic cannabinoid agonist
Ajulemic acid is a synthetic analog of ∆8‐THC‐11‐oic acid, the terminal metabolite of ∆8‐THC. Unlike ∆9‐THC, the psychoactive… 
2009
2009
Positive allosteric modulatory effects of ajulemic acid at strychnine-sensitive glycine α1- and α1β-receptors
The synthetic cannabinoid ajulemic acid (CT-3) is a potent cannabinoid receptor agonist which was found to reduce pain scores in… 
2007
2007
Suppression of fibroblast metalloproteinases by ajulemic acid, a nonpsychoactive cannabinoid acid
Production of matrix metalloproteinases (MMP) in joint tissue of patients with inflammatory arthritis facilitates cartilage… 
2007
2007
Comments on “Cannabimimetic Properties of Ajulemic Acid”
This is a commentary on recent preclinical findings of ajulemic acid (AJA), also known as CT-3, suggesting an unfavorable… 
2007
2007
In humans, ajulemic acid has a more favorable side-effect profile than THC for the treatment of chronic neuropathic pain
This is a comment on a report by Vann et al. (2006) on the pharmacological effects of ajulemic acid compared to CB1 receptor… 
Review
2007
Review
2007
Letter: Preclinical assessment of abuse liability of ajulemic acid
The primary underlying issue that Dr. Burstein raises in his comment [4] on the Vann et al. manuscript [7] is one of predictive… 
Review
2005
Review
2005
Ajulemic acid.
  • J. Wiley
  • IDrugs : the investigational drugs journal
  • 2005
  • Corpus ID: 1616393
Indevus Pharmaceuticals Inc is developing ajulemic acid, a non-steroidal anti-inflammatory drug derived from tetrahydrocannabinol… 
Highly Cited
2001
Highly Cited
2001
Antitumor effects of ajulemic acid (CT3), a synthetic non-psychoactive cannabinoid.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)